Intellia Therapeutics Inc


NTLA

Price

27.51


Change

0.49


High

NA


Low

NA


Avg Volume

1,513,336


PE Ratio

-5.08


52 Week High

47.48


52 Week Low

22.67



Profile

Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and Virginijus Šikšnys . The company has partnerships with Novartis and Regeneron. Intellia Therapeutics was founded in May 2014 to develop biopharmaceuticals using CRISPR.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.